Crossmark

Bioavailability enhancement of vitamin E TPGS liposomes of nintedanib esylate: formulation optimization, cytotoxicity and pharmacokinetic studies

Published Online: 2022-03-23

Published Print: 2022-11

Authors

Kala, Shabari Girinath https://orcid.org/0000-0002-0856-5597
Chinni, Santhivardhan https://orcid.org/0000-0003-0774-2026
License Information

Text and Data Mining valid from 2022-03-23

Version of Record valid from 2022-03-23
More Information

Article History

Accepted: 4 March 2022

First Online: 23 March 2022

Declarations

:

: The study protocol (IAEC/JLS/16/07/21/42) for animal experiments was approved by the institutional animal ethics committee (IAEC) under committee for the purpose of control and supervision of experiments on animals (CPCSEA) guidelines.

: Not applicable.

: The authors declare no competing interests.

Document is current